Mon, Dec 29, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Barclay Hedge Fund Index down -0.96% in June (+0.13% YTD), Fund of Funds Index -0.74% in June (-1.34% YTD)

Friday, July 16, 2010
Opalesque Industry Updates - Hedge funds lost 0.96% in June according to the Barclay Hedge Fund Index compiled by BarclayHedge. The Index is now up 0.13% year-to-date.

All but five of Barclay’s hedge fund indexes lost ground in June. The Barclay Equity Long Bias Index fell 2.95%, Healthcare and Biotechnology lost 2.62%, the Technology Index was down 2.22%, Equity Long/Short lost 1.78%, and Pacific Rim Equities were down 1.52%.

“Fears of a ‘double-dip’ recession helped drive equity markets lower for a second month,” says Sol Waksman, founder and president of BarclayHedge.

Four hedge fund strategies performed well in June. The Barclay Equity Short Bias Index jumped 4.08%, Fixed Income Arbitrage was up 0.75%, Merger Arbitrage gained 0.60% and the Convertible Arbitrage Index rose 0.31%.

“On the other side of the flight to quality trade, prices for US 10-year Treasuries rose two percent in June as risk-adverse traders sold stocks and then bought bonds with the proceeds,” says Waksman.

The two best performing hedge fund sectors in 2010 are the Distressed Securities Index, up 6.26% after two quarters, and the Fixed Income Arbitrage Index which has gained 5.53%.

“The ongoing rally in bond markets has been the ‘wind behind the sails’ for sectors that are interest rate sensitive,” says Waksman.

The Barclay Fund of Funds Index lost 0.74% in June, and is down 1.34% year-to-date.

Performance table available: Source kb

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its